The hormonal properties of vitamin D3, as part of the vitamin D3 endocrine system, may be responsible for the increased efficacy of tamoxifen, a selective inhibitor of estrogen receptor (ER) commonly applied in breast cancer therapy [35]. The gene discussed is ESR1; the disease is breast cancer.